Fig. 3From: Prognostic benefit of conversion surgery for HER2 positive stage IV gastric cancer; a case series study of eleven patients treated with trastuzumab-based chemotherapyKaplan–Meier analysis demonstrated that patients who received conversion surgery showed significantly better overall survival than those without conversion surgery (chemotherapy alone) (P = 0.03)Back to article page